Symbol | Company | Weighting |
---|---|---|
GH | GUARDANT HEALTH INC | 2.86% |
ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.53% |
SMMT | SUMMIT THERAPEUTICS INC. | 2.40% |
PEN | PENUMBRA INC | 2.35% |
AXSM | AXSOME THERAPEUTICS INC. | 2.22% |
LLY | ELI LILLY CORP | 2.20% |
MCK | MCKESSON CORP | 2.20% |
TVTX | TRAVERE THERAPEUTICS INC | 2.16% |
SNY | SANOFI- AVENTIS- ADR | 2.14% |
ALC | ALCON INC | 2.11% |
ABT | ABBOTT LABORATORIES | 2.10% |
BSX | BOSTON SCIENTIFIC | 2.10% |
AZN | ASTRAZENECA PLC-ADR | 2.09% |
ELV | ELEVANCE HEALTH INC | 2.07% |
MOH | MOLINA HEALTHCARE INC | 2.02% |
ARGX | ARGENX SE ADR | 1.99% |
MRUS | MERUS NV | 1.97% |
HCA | HCA HOLDINGS INC | 1.91% |
ISRG | INTUITIVE SURGICAL INC | 1.90% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.89% |
CI | THE CIGNA GROUP | 1.88% |
SYK | STRYKER CORP | 1.84% |
INSM | INSMED INC | 1.83% |
AMLX | AMYLYX PHARMACEUTICALS INC | 1.82% |
NAMS | NEWAMSTERDAM PHARMA CO NV | 1.78% |
THC | TENET HEALTHCARE CORP | 1.77% |
DXCM | DEXCOM INC | 1.76% |
RMD | RESMED INC | 1.75% |
BDX | BECTON DICKINSON & CO | 1.66% |
SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.65% |
ZTS | ZOETIS INC | 1.64% |
MRK | MERCK & CO. NEW | 1.63% |
HUM | HUMANA INC | 1.62% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.60% |
CYTK | CYTOKINETICS INC | 1.59% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.58% |
RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.57% |
NUVL | NUVALENT INC | 1.56% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.56% |
GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.52% |
CNTA | CENTESSA PHARMACEUTI | 1.52% |
COO | COOPER COS INC | 1.51% |
ABVX | ABIVAX SA | 1.49% |
REGN | REGENERON PHARMACEUTICALS | 1.47% |
IDYA | IDEAYA BIOSCIENCES, INC | 1.46% |
BIIB | BIOGEN INC | 1.42% |
ICLR | ICON PLC | 1.40% |
ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.37% |
RVMD | REVOLUTION MEDICINES INC | 1.32% |
UNH | UNITEDHEALTH GROUP INC | 1.27% |
GKOS | GLAUKOS CORPORATION | 1.22% |
IMTX | IMMATICS NV | 1.19% |
NVO | NOVO NORDISK A/S | 1.15% |
IMVT | IMMUNOVANT INC | 1.15% |
TNDM | TANDEM DIABETES CARE INC | 1.04% |
EWTX | EDGEWISE THERAPEUTICS | 0.95% |
ARVN | ARVINAS INC USD | 0.79% |
PCVX | VAXCYTE INC | 0.78% |
GERN | GERON CORP | 0.66% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.